PLRX insider buying and SEC filings, explained
Pliant Therapeutics, Inc. · CIK 1746473
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$164K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jan 20, 2026 | Planned (10b5-1) | Keith Lamont Cummings (CFO) sold 24,002 shares at about $1.28 ($31K), marked as a 10b5-1 plan trade. Holdings down 7% to 297,214 shares. | SEC filing Filed Jan 22, 2026 |
| Jan 20, 2026 | Planned (10b5-1) | Lily Cheung (Chief Human Resource Officer) sold 7,534 shares at about $1.28 ($10K), marked as a 10b5-1 plan trade. Holdings down 14% to 44,847 shares. | SEC filing Filed Jan 22, 2026 |
| Jan 20, 2026 | Planned (10b5-1) | Bernard Coulie (CEO and Director) sold 89,375 shares at about $1.28 ($114K), marked as a 10b5-1 plan trade. Holdings down 15% to 505,601 shares. | SEC filing Filed Jan 22, 2026 |
| Jan 20, 2026 | Planned (10b5-1) | Minnie Kuo (President / COO) sold 6,917 shares at about $1.28 ($9K), marked as a 10b5-1 plan trade. Holdings down 15% to 37,806 shares. | SEC filing Filed Jan 22, 2026 |
17 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow PLRX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.